Drugmakers to report on drug samples

Published: 2009-01-08 06:58:00

Updated: 2009-01-08 06:58:00

Pharmaceutical firms are obligated to report their handling of drug samples to the Health Insurance Review and Assurance Service (HIRA) from this year, it was announced on January 5.

According to the HIRA, “non-commercial purpose” in the remarks should be indicated in a report form in additi...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK